已收盘 12-19 16:00:00 美东时间
-0.285
-2.56%
Biohaven Ltd. (NYSE:BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases,
11-12 05:06
Biohaven stock plunged after the FDA rejected Vyglxia for spinocerebellar ataxia, prompting major R&D cuts and a William Blair downgrade.
11-06 01:53
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gai...
11-06 01:05
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining mor...
11-03 21:14
北京时间2024年12月14日03时44分,Biohaven Ltd.(BHVN.us)股票出现波动,股价大幅跳水5.18%。截至发稿,该股报38.08美元/股,成交量53.4139万股,换手率0.53%,振幅5.80%。 最近的财报数据显示,该股实现营业收入0.00美元,净利润-1.60亿美元,每股收益-1.70美元,毛利-1000000.00美元,市盈率-4.06倍。 机构评级方面,在所有15家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。 Biohaven Ltd.股票所在的生物技术行业中,整体跌幅为0.08%。其相关个股中,Innate Pharma、60 D...
2024-12-14 03:44
金吾财讯 | Scholar Rock(SRRK)盘初急升,截止发稿,涨31.12%,报39.23美元,成交额6181.45万美元。 消息面上,竞争对手生物制药公司biohaven(BHVN)表示,其针对脊髓性肌肉萎缩症的实验药物的研究在48周内与安慰剂和标准护理相比没有达到"统计学显著差异"。
2024-11-25 22:41
Cantor Fitzgerald analyst Charles Duncan reiterates Biohaven (NYSE:BHVN) with a Overweight.
2024-09-24 20:30
U.S. stocks traded higher toward the end of trading, with the Dow Jones index g...
2024-09-24 02:35
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Comp...
2024-09-24 00:18
BDTX: 54% | Black Diamond Therapeutics shares are trading higher after the company announced initial Phase 2 data demonstrating encouraging clinical responses and durability of BDTX-1535 in patients with
2024-09-23 20:10